U.S. Hotel and Resort REITs Stock News

Peloton Interactive stock inched up 3.1% to US$5.68 after earnings, a modest move for a company that just logged its first full year of positive operating and net income. Traders are reacting to the headline profit. Long term investors are staring at something else entirely. The stock still sits on a 7 day decline of roughly 11% and carries a rich trailing P/E of 39.4x against leisure peers. The real story this quarter is the balance sheet and valuation strain. Profit is now on the table, yet...

Chord Energy (CHRD) is back in focus after reporting better than expected quarterly revenue, strong adjusted free cash flow of $414 million, and a plan to return at least 75% of that cash to shareholders. See our latest analysis for Chord Energy. That backdrop of strong Q2 cash generation, higher targeted capital returns and ongoing buybacks has come after a mixed stretch for Chord Energy's stock, with the share price down 6.43% over the last week but up 7.55% over the past month and showing...

CareTrust REIT stock barely moved after earnings, up only 0.2% to US$41.22, yet the results were anything but quiet. The market shrugged. The quarter did not. The real story sits in the cash engine that investors in health care real estate care most about. Normalized funds from operations per share jumped to US$0.51, with normalized funds available for distribution also at US$0.51. Management raised full year guidance for both measures. For a stock that has drifted over the past three months,...

Liberty Capital stock barely budged on the earnings print, up only 0.6% to about $24.60, even though the headline was big for a capital intensive telecom player. The company put a dividend on the table and sharpened its cash story, all while reporting Q2 revenue of $261m and adjusted operating income before depreciation and amortization of $96m. In the very near term, the market seems cautious and focused on modest moves. The main question for investors is how this new dividend and potential...

nLIGHT stock just dropped 26% in regular trading, yet the earnings story is more complicated than the price chart suggests. The company posted record Q2 revenue of about US$82.6 million and generated roughly US$20.7 million in operating cash flow, while still reporting a GAAP net loss of US$1.3 million. In the short term, investors are reacting to that loss and a softer Q3 guide. In the longer term, the real debate is whether a rich P/S multiple near 10x and a sizeable loss-making base can be...

BRC Group Holdings stock slipped about 1% today to US$7.18, which is a muted move given the size of the earnings swing investors are processing. The company just posted Q2 net income of US$18.5m with adjusted operating earnings before interest, tax, depreciation and amortisation of US$66m, described as its strongest core operating quarter in nearly three years. Short term traders are still focused on a share price that has fallen over the past three months. Longer term investors are weighing...

In late July 2026, Del Monte Corporation reported second-quarter 2026 results showing sales of US$1,219.1 million, up from US$1,182.5 million a year earlier, while net income fell to US$21.2 million from US$56.8 million and diluted EPS from continuing operations eased to US$0.44 from US$1.18. At the same time, the board declared a quarterly cash dividend of US$0.30 per share, highlighting an ongoing capital return commitment even as earnings for both the quarter and first half of 2026 were...

Viridian Therapeutics stock climbed about 5% today, yet the headline from this quarter is not a sudden profit swing. The story is a widening loss set against a biotech pipeline that still sits in heavy investment mode. In Q2, Viridian reported basic earnings per share of a loss of US$1.18 and a net loss of about US$127.1 million on revenue of just US$0.3 million. For a development stage biotech this kind of margin squeeze can either be growing pains or a red flag. The following sections...

Currency markets are back in the spotlight after US and Japanese authorities moved to support the yen and rattled global equities. A stronger US dollar can quietly reshape winners and losers, especially for companies with overseas cost bases or import heavy models. This article walks through three stocks from our US Dollar Beneficiaries screener that appear positioned to feel the impact, so you can decide whether they deserve a spot on your watchlist. The stocks covered below are just a...

Trade Desk (NasdaqGM:TTD) reported Q2 2026 revenue growth of 3%, which stalled relative to prior quarters and missed market expectations. Management pointed to tighter budgets from major advertisers as a key factor behind the shortfall. The CEO highlighted that growth is increasingly coming from smaller, challenger and ecommerce focused brands, along with international markets. This shift in revenue mix raised fresh questions about Trade Desk’s reliance on large legacy advertisers and its...

Serve Robotics stock just dropped 10% today, yet the real shock is not the share price. The reset in full year revenue guidance to US$9 to 10 million, down sharply from US$26 million, is what is driving the sentiment break. A quarterly revenue line of US$3.2 million now sits against a Q2 net loss of US$64 million, which is a wide gap for any growth story. For investors, today is less about robots and more about trust in the economic model. The market is asking whether this guidance reset is a...

National HealthCare stock slipped about 3% today to US$212.72, even though the latest quarter showed profit power that long term holders will likely care more about than a single red day on the screen. Earnings per share in Q2 came in at US$2.58 on revenue of US$408.03m, backing up a trailing net profit margin of 9% and a P/E of 24x that still sits just under healthcare peers. The headline is simple: the price is cooling in the short term while the earnings base and valuation case remain the...

Delcath Systems stock slipped 2.3% to US$15.11 in the first full session after earnings, yet the quarter itself read more like a quietly confident step forward than a setback. The company delivered Q2 2026 revenue of US$29.1m and moved from recent quarterly losses to a profit of US$2.7m. For a high fixed cost medical equipment business, that swing into the black is the real headline and sets up the rest of the numbers that investors now need to examine more closely. Is Delcath Systems really...

RE/MAX Holdings stock jumped about 5% today, a punchy move for a franchise-heavy real estate brand that has been wrestling with losses. The headline this quarter is simple. The company is still in the red, but the loss narrowed meaningfully compared with the prior quarter, and that is what the market is latching onto. Short term traders are reacting to the bounce. Longer term investors are weighing a different question: Can a business with trailing losses and pressure on interest coverage...

Earnings Beat on Revenue, Pressure on Profitability U.S. Physical Therapy (USPH) reported second quarter 2026 results that combined higher revenue with weaker profitability. Revenue slightly surpassed analyst expectations, while earnings per share came in below forecasts and declined compared to the prior year. For the quarter ended June 30, 2026, revenue was reported at $214.06 million, compared with $197.34 million a year earlier. Net income was $9.9 million versus $12.39 million in the...

In early August 2026, Teradata Corporation reported second-quarter 2026 results showing higher sales of US$363 million, revenue of US$410 million, sharply improved net income of US$46 million, and raised full-year GAAP diluted EPS guidance to a range of US$4.43 to US$4.51. At the same time, Teradata expanded its board with the appointment of technology veteran Bernd Leukert and broadened its AI-focused product reach by launching its enterprise-grade Data Analyst Agent on Amazon Web Services...

Vertex Pharmaceuticals stock has delivered a strong 155.4% return over the past 5 years, yet the current valuation picture is mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to some upside while the broader checks look less supportive. Over 5 years, Vertex Pharmaceuticals has returned 155.4%, which puts recent pricing against a backdrop of already strong gains. Expectations around new therapies and pipeline catalysts may support the current share price, while...

Event driven look at Jones Lang LaSalle stock Jones Lang LaSalle (JLL) is back on investors radar after its latest quarterly update showed higher sales and net income for both the second quarter and first half of 2026. See our latest analysis for Jones Lang LaSalle. At a share price of $362.38, Jones Lang LaSalle has a 30 day share price return of 11.84% and a 90 day share price return of 9.86%, while the 1 year total shareholder return of 30.25% and 3 year total shareholder return of 107.76%...

Devon Energy stock has almost doubled investors' money over the past five years, yet the market still prices it on metrics that screen as undervalued and the broader valuation checks lean supportive rather than stretched. Devon Energy has returned 96.5% over five years, which keeps the stock in focus for investors who want to know if the current price still leaves room for attractive risk adjusted returns. The recent merger with Coterra and higher production plans can support expectations...

Why Marvell Technology Stock Is Back in Focus After New AI Memory Launch Marvell Technology (MRVL) is back on investors’ radar after unveiling a broad AI memory infrastructure lineup that targets hyperscalers and cloud providers looking to scale large model inference more efficiently. The new portfolio covers server level storage, rack scale CXL memory expansion and an optical shared memory tier designed to support heavier AI inference workloads. For shareholders, the announcement raises...

In early August 2026, Broadridge Financial Solutions reported higher fourth-quarter and full-year earnings, approved a 12% annual dividend increase to US$4.36 per share, launched a new US$1.50 billion share repurchase program, and expanded its unified governance platform to support proxy voting for tokenized equities via Payward Services’ xStocks framework. Together, these moves highlight Broadridge’s push to link traditional proxy infrastructure with blockchain-based securities while...

HCI Group stock came into this earnings season already on a tear, with a 90 day return of about 24%. The market liked what it saw again. Shares jumped another 4.3% to US$188.69 in the first full session after results. The headline is not just another solid quarter. HCI Group delivered Q2 pretax income of more than US$110m and kept its combined ratio near 61%, which is unusually low for a catastrophe exposed insurer. That mix of strong underwriting profitability and growing premium volume is...

Alkermes earnings update and new guidance Alkermes (NasdaqGS:ALKS) stock is in focus after the company reported second quarter 2026 results, issued third quarter and full year earnings guidance that points to a GAAP net loss, and filed a new shelf registration. The fresh information gives you several moving parts to weigh. Revenue, profitability guidance, previous share repurchases and potential future ordinary share issuance can all affect how you think about Alkermes as an investment...

Capri Holdings (CPRI) stock is back in focus after first quarter earnings on August 5, 2026, reported higher net income and EPS on slightly lower sales, along with detailed revenue and profit guidance. See our latest analysis for Capri Holdings. The Capri Holdings share price closed at US$15.31 on August 6, 2026, and despite a 1 day share price return of 2.07% after the earnings release, momentum has been weak with the 30 day share price return down 14.47% and the 1 year total shareholder...